Hugo Ribeiro: Which NSAIDs Are Safest for Older Adults?
Hugo Ribeiro, Invited Specialist of Palliative Medicine at European Commission, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in BioChem, adding:
“I am delighted to announce that our article ‘Appropriate Prescription of Non-Steroidal Anti-Inflammatory Drugs in Geriatric Patients—A Systematic Review’, published in BioChem, was selected as an Editor’s Choice article.
This recognition highlights our work as one of the most significant and high-quality articles published in this journal.
This systematic review of 39 studies (patients more than 65 years) compares the safety of ibuprofen, naproxen, acemetacin, diclofenac, celecoxib, and etoricoxib.
Celecoxib has a more favorable GI, renal and CV safety profile versus the other studied NSAIDs. Acemetacin shows a promising greater safety profile but remains unproven and requires dedicated research.
Diclofenac and etoricoxib are linked to higher cardiovascular risk. Evidence is limited by heterogeneity and scarce geriatric-specific data overall.
Congratulations to all authors, specially to Dr. Carolina Costa! Prof. Andrade Jose Paulo, Dr. Diana Soares, Dr. Ana Borges and Dr. Ana Gonçalves.”
Title: Appropriate Prescription of Non-Steroidal Anti-Inflammatory Drugs in Geriatric Patients—A Systematic Review
Authors: Carolina Costa, Diana Soares, Ana Borges, Ana Gonçalves, José Paulo Andrade, Hugo Ribeiro
Stay updated with Hemostasis Today.
-
Oct 12, 2026, 13:58Francisco Chacón-Lozsán: Catastrophic Antiphospholipid Syndrome A Rapidly Progressive Multiorgan Thrombotic Emergency
-
Oct 12, 2026, 12:50Nawsherwan Mohammad: Study Examines Thrombotic Events in Patients with Polycythemia Vera in Iraq
-
Oct 12, 2026, 12:30Chanakya Nayudu: Looking Beyond Blood Clots – Patient-Reported Outcomes in Antiphospholipid Syndrome
-
Oct 12, 2026, 12:12Jean-Jacques Kiladjian: Improving Treatment Strategies with JAK Inhibitors in Myelofibrosis
-
Oct 12, 2026, 12:04Chloe Homich: AABB Annual Meetings – Building Connections and Advancing Transfusion Medicine
-
Oct 12, 2026, 11:51Daniel Sop: Sickle Cell Research Takes Center Stage at ASCAT 2026
-
Oct 12, 2026, 10:36PAI-1 Inhibition as a New Strategy for Enhancing Fibrinolysis and Clot Resolution
-
Oct 12, 2026, 07:39Emmanuel J Favaloro: 100 Years of von Willebrand Disease and the Importance of Local Diagnosis and Management
-
Oct 12, 2026, 07:39Post-Stroke Fatigue Trajectories – 38% Recovered at 12 Months, While 16% Developed New Fatigue – International Journal of Stroke